Search results for "Histiocytosis"

showing 10 items of 55 documents

Erythrophagocytic tumour cells in melanoma and squamous cell carcinoma of the skin

1997

Aims: Erythrophagocytosis is a characteristic feature of tumour cells in malignant histiocytosis, some leukaemias, lymphomas, and also reactive histiocytes in the haemophagocytic syndrome associated with a variety of infections and neoplasms. It has also been found exceptionally in metastatic malignant epithelial cells in bone marrow and lymph nodes. We present two cases, a cutaneous malignant melanoma and an acantholytic squamous cell carcinoma, in which erythrophagocytosis by tumour cells was demonstrable by both light and electron microscopy. Methods and results: The melanocytic and squamous nature of these cells was supported by the immunohistochemical detection of HMB45, S100, and NKI-…

MalePathologymedicine.medical_specialtyErythrocytesSkin NeoplasmsHistologyMalignant histiocytosisBiologyPathology and Forensic MedicineCytokeratinPhagocytosisAntigens NeoplasmBiomarkers TumormedicineHumansMelanomaHistiocyteAgedAged 80 and overMelanomaMucin-1General Medicinemedicine.diseaseImmunohistochemistryErythrophagocytosisNeoplasm ProteinsMicroscopy ElectronHaematopoiesismedicine.anatomical_structureEpidermoid carcinomaCarcinoma Squamous CellBone marrowMelanoma-Specific AntigensHistopathology
researchProduct

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification

2007

Multisystem Langerhans cell histiocytosis (MS-LCH) is associated with high mortality when patients have risk organ involvement (RO+) or are younger than 2 years. In an international randomized trial, LCH-II, we intensified their treatment: arm A consisted of 6 weeks of daily prednisone and weekly vinblastine followed by 18 weeks of daily 6-mercaptopurine with vinblastine/prednisone pulses; etoposide was added in arm B. Considering all 193 randomized risk patients, there were similar outcomes: rapid (6 weeks) response (arm A vs arm B: 63%/71%), 5-year survival probability (74%/79%), disease reactivation frequency (46%/46%), and permanent consequences (43%/37%). However, (1) patients younger …

Malemedicine.medical_specialtyImmunologyAdult Langerhans Cell HistiocytosisBiochemistryGastroenterologylaw.inventionLangerhans cell histiocytosisRandomized controlled trialRisk FactorsPrednisonelawInternal medicineHumansMedicineEtoposideDemographyHematologybusiness.industryInfantCell BiologyHematologymedicine.diseaseSurgeryVinblastineSurvival RateHistiocytosis Langerhans-CellTreatment OutcomeChild PreschoolOrgan involvementFemalebusinessmedicine.drugBlood
researchProduct

Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review

2012

Summary Background Inflammatory bowel disease (IBD) patients are at increased risk of cytomegalovirus (CMV) reactivation, and although CMV pneumonia may be a fatal disease in IBD patients, little information is available on this issue. The objectives of this study were to identify risk factors for the development of CMV pneumonia in IBD patients and to find useful information to better manage this potentially fatal complication. Methods A computerized search without language restrictions was conducted using PubMed and SCOPUS. An article was considered eligible for inclusion in the systematic review if it reported detailed data on patients with IBD presenting with pneumonia due to CMV. Resul…

Microbiology (medical)AdultMalePediatricsmedicine.medical_specialtyPneumonia ViralCongenital cytomegalovirus infectionCytomegalovirusHemophagocytic lymphohistiocytosisTachypneaInflammatory bowel diseaseInflammatory bowel diseaseRisk FactorsIntensive caremedicineHumanspneumoniapneumonia; Inflammatory bowel disease; CytomegalovirusCrohn's diseasesHemophagocytic lymphohistiocytosisbusiness.industryGeneral Medicinemedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisSurgeryPneumoniaInfectious DiseasesUlcerative colitisCytomegalovirus InfectionsFemaleVirus Activationmedicine.symptomComplicationbusiness
researchProduct

Scrub typhus, acute respiratory distress, and hemophagocytic lymphohistiocytosis

2013

.

Microbiology (medical)MalePediatricsmedicine.medical_specialtyHemophagocytic lymphohistiocytosisRespiratory Distress SyndromeScrub typhubusiness.industryScrub typhus; acute respiratory distress; hemophagocytic lymphohistiocytosis.General MedicineScrub typhusAcute respiratory distresshemophagocytic lymphohistiocytosis.Liver Failure Acutemedicine.diseaseInfectious Diseaseshemophagocytic lymphohistiocytosisScrub typhusmedicineHumansbusinessacute respiratory distreacute respiratory distressInternational Journal of Infectious Diseases
researchProduct

Measles and Secondary Hemophagocytic Lymphohistiocytosis

2012

To the Editor: We found interesting the article by Lupo et al. about a case of fatal measles in an immunocompetent 29-year-old woman (Fatal measles without rash in immunocompetent adult, France; http://dx.doi.org/10.3201/eid1803.111300). Perhaps, however, the possible diagnosis of secondary hemophagocytic lymphohistiocytosis (HLH) should also have been considered in that setting. HLH is a potentially fatal hyperinflammatory syndrome characterized by histiocyte proliferation and hemophagocytosis. HLH may be inherited (i.e., primary, familial, generally occurring in infants) or may occur at any age secondary to infection, malignancy, or rheumatologic disease. Secondary HLH is determined accor…

Microbiology (medical)Secondary Hemophagocytic LymphohistiocytosisLetterEpidemiologylcsh:Medicinerashacute lymphocytic leukemiaMeaslesArticlelcsh:Infectious and parasitic diseasespancytopeniadeathhemic and lymphatic diseasesAcute lymphocytic leukemiamedicineHumanspneumoniaviruseslcsh:RC109-216Letters to the EditorHistiocyteCytopeniahemophagocytosisbusiness.industrylcsh:RExanthemaacute respiratory distress syndromemedicine.diseasesecondary hemophagocytic lymphohistiocytosisPancytopeniaPneumoniaInfectious DiseasesImmunologyFemaleFranceHemophagocytosisbusinessMeaslesEmerging Infectious Diseases
researchProduct

Visceral leishmaniasis, hypertriglyceridemia and secondary hemophagocytic lymphohistiocytosis

2016

cytokines, an upregulation of adhesion molecules and MHC I and II molecules on mono/macrophages, and an expansion of inflammatory monocytes. This exaggerated inflammatory response is responsible for necrosis and organ failure and results in uncontrolled proliferation and phagocytic activity of histiocytes [2]. Hypertriglyceridemia (fasting, greater than or equal to 265 mg/100 ml) is one of the current diagnostic criteria for HLH [2]. Several studies link hypertriglyceridemia to inhibition of lipoprotein lipase (LPL) by tumor necrosis factor-α (TNF-α), and TNF-α is a powerful autocrine and paracrine regulator of adipose tissue [3]. Indeed, many different sources of intense and prolonged T-ly…

Microbiology (medical); Infectious Diseases0301 basic medicineMicrobiology (medical)Secondary Hemophagocytic LymphohistiocytosisNecrosisSettore MED/17 - Malattie Infettive030106 microbiologyAdipose tissueTriglycerideSeverityLymphohistiocytosis Hemophagocytic03 medical and health sciences0302 clinical medicinemedicineHumansMacrophage030212 general & internal medicineVisceral leishmaniasisHypertriglyceridemiaLipoprotein lipasebusiness.industryAnemia; Severity; Triglyceride; Visceral leishmaniasisHypertriglyceridemiaAnemiaGeneral Medicinemedicine.diseaseInfectious DiseasesVisceral leishmaniasisImmunologyLeishmaniasis VisceralTumor necrosis factor alphamedicine.symptombusinessInfection
researchProduct

Response to initial treatment of multisystem langerhans cell histiocytosis: An important prognostic indicator

2002

Background Reliable prediction of prognosis allowing risk-adapted therapy remains a major issue in the management of multisystem Langerhans cell histiocytosis (LCH). In a recent publication of the International LCH Study Group, response to initial therapy appears to be a reliable outcome predictor. The aim of this study is to test this observation in a cohort of patients treated with more intensive initial therapy. Furthermore, we compare the predictive value of response to initial therapy to some other well-established stratification systems. Procedure Response to initial combination chemotherapy (prednisolone, vinblastine, and etoposide) at 6 weeks and its prognostic value was evaluated r…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryRetrospective cohort studyCombination chemotherapymedicine.diseaseSurgeryHistiocytosisPharmacotherapyOncologyLangerhans cell histiocytosisInternal medicinePediatrics Perinatology and Child HealthCohortmedicinePrednisolonebusinessSurvival ratemedicine.drugMedical and Pediatric Oncology
researchProduct

INTERNATIONAL JOURNAL OF CLINICAL DENTISTRY

2018

Diagnosis and Management of Oral Langerhans Cell Histiocytosis Emanoele Paixão da Silva Silva, Carina Myung Rodenbeck, Monira Samáan Kallas, Cássia Maria Fischer Rubira, and Paulo Sérgio da Silva Santos Mandibular-Infected Buccal Cyst: Unique Radiographic Appearance Gustavo Zanna Ferreira, Cássia Maria Fischer Rubira, Letícia Rodrigues Nery, Alberto Consolaro, Izabel Regina Fischer Rubira-Bullen, and Paulo Sérgio da Silva Santos PRF - The Magical Resort in Surgical Dentistry Archana Mootha, Julie Toby Thomas, Sankari Malaiappan, Sheeja S. Varghese, and N. D. Jayakumar Endodontic Management of a Macrodont: A Rare Tooth Anomaly Rahul Rathi and Priti Saroha Maxillary Canine Root Resorption Con…

Oral Langerhans Cell HistiocytosisBuccal CystSurgical DentistryMacrodontRoot ResorptionTooth DiscolorationAntifungal AgentGuided Bone RegenerationDentin Dysplasia Type IILinear Measurement in Dental Implant SiteENDODONTIC BIOFILM
researchProduct

Langerhans's cell histiocytosis in old subjects: two rare case reports and review of the literature

2012

Background: Langerhans cell histiocytosis (LCH) is a proliferative disease of histiocyte-like cells that generally affects children; LCH onset is rare in adults; immunohistochemistry is essential to obtain the correct diagnosis, and treatment protocols are controversial. Objective: To describe two new cases of adult onset oral LCH. Case reports: Case 1: a 71-year-old woman, complaining of diffuse oral pain, presented with erythematous mucosal lesions; the panoramic radiograph and CT scan showed multiple mandible radiolucent areas. Immunohistochemical assay for S-100, CD1a and langerin test was essential in reaching the correct diagnosis. Case 2: a 77-year-old female patient presented with a…

PalateLangerhans's cell histiocytosisS100 ProteinsAntineoplastic AgentsAntineoplastic Agents Phytogeniclangerhans’s cell histiocytosis old subjects langerin oral immunohistochemistryAntigens CD1Diagnosis DifferentialSettore MED/28 - MALATTIE ODONTOSTOMATOLOGICHEHistiocytosis Langerhans-CellMannose-Binding LectinsAntigens CDErythemaCladribineHumansFemaleLectins C-TypeMandibular DiseasesRadiotherapy AdjuvantVulvar DiseasesMouth DiseasesPeriodontal DiseasesAgedEtoposide
researchProduct

A rare case of solitary brain Langerhans cell histiocytosis with intratumoral hemorrhage in a patient affected by Turner syndrome

2016

Background: Langerhans cell histiocytosis (LCH) is a rare disease involving clonal proliferation of cells with characteristics similar to bone marrow-derived Langerhans cells. The case of a young woman, affected by Turner syndrome and a solitary intraparenchymal LCH associated with an osteolytic lesion of the overlying skull, is presented. Case Description: The patient, with an insidious history of headache and a growing soft mass in the left frontal region, presented with a sudden generalized tonic-clonic epileptic seizure. Neuroradiological investigations showed an osteolytic lesion of the left frontal bone and an underlying brain lesion associated with recent signs of bleeding. The patie…

Pathologymedicine.medical_specialtyCase ReportHemorrhageHemorrhage Langerhans cell histiocytosis skull neoplasm03 medical and health sciences0302 clinical medicineLangerhans cell histiocytosisTurner syndromeRare caseMedicineskull neoplasmbusiness.industryPatient affectedLangerhans cell histiocytosiLangerhans cell histiocytosisSkull Neoplasmmedicine.diseaseHemorrhage; Langerhans cell histiocytosis; skull neoplasmOsteolytic lesionSkullmedicine.anatomical_structure030220 oncology & carcinogenesisSurgeryNeurology (clinical)business030217 neurology & neurosurgeryRare diseaseSurgical Neurology International
researchProduct